source
- Dr Olawaiye on the FDA Approval of Relacorilant Plus Nab-Paclitaxel in PROCAlexander B. Olawaiye, MD, discusses the clinical significance of the FDA approval of relacorilant plus nab-paclitaxel in PROC.onclive · 2mo ago↗ source
- Official leading CDC’s cruise ship program retiresThe hantavirus outbreak on the MV Hondius has focused the public's attention on cruise ship safety.STAT · 2mo ago↗ source
- Daraxonrasib Monotherapy Elicits Meaningful Responses in Previously Treated, RAS-Mutated Pancreatic CancerPhase 1/2 data showed an ORR of 35% with daraxonrasib in second-line RAS G12-mutated pancreatic ductal adenocarcinoma.onclive · 2mo ago↗ source